Delivery details +
Order by fax
Thailand Pharmaceuticals and Healthcare Report Q4
- PDF: Immediate delivery
Thailand Pharmaceuticals and Healthcare Report Q4
2012
- Product Code:BMI06587
- Publication Date:September 2012
- Publisher:Business Monitor
- Product Type: Report
- Pages:96
- ISBN:1748-2240
Thailand Pharmaceuticals and Healthcare Report Q4 2012
BMI View: Over the medium to long term, Thailand will be facing intensive competition from neighbouring countries such as Malaysia, Indonesia and Philippines as they roll out plans to improve healthcare coverage and boost growth in the pharmaceutical industry. The intense competition coupled with the usage of compulsory licenses, regulatory lapses and widespread corruption will deter foreign investments into the sector. Despite this we highlight that the country's strong medical tourism sector and the impending implementation of the ASEAN Economic Committee will continue to attract private healthcare providers (and the related sub-sectors) into the country. Headline Expenditure Projections
- Pharmaceuticals: THB130.95bn (US$4.41bn) in 2011 to THB136.16bn (US$4.18bn) in 2012;
- Healthcare: THB410.20bn (US$13.46bn) in 2011 to THB425.32bn (US$13.05bn) in 2012;
- Medical devices: THB33.88bn (US$1.11bn) in 2011 to THB38.95bn (US$1.20bn) in 2012;
- In June 2012, US-based BHR Pharma expanded its SyNAPSe clinical trial at 14 sites in Thailand, China and Russia. The trial has 153 participating sites worldwide. The 500th of 1,180 patients is required to conclude the global phase III, multi-centre trial, which was registered in the US at the end of May 2012. SyNAPSe is assessing the effectiveness of BHR-100, a proprietary intravenous progesterone infusion formulation, as a neuroprotective agent to treat traumatic brain injury (TBI) patients. Thailand Pharmaceuticals and Healthcare Report Q4 2012
- In May 2012, GlaxoSmithKline (GSK)'s country office in Thailand has developed the Medicine Bank initiative to increase access to drugs in the country. The company is working with the Thai Red Cross and the Royal Thai Army to provide and supply medicine and sanitary supplies. The company and the Thai Red Cross offer health education and vaccines to disadvantaged people for diseases, including infant diarrhoea, influenza and pneumonia. These diseases are the main causes of death among young children in the country. GSK also offers medical and sanitary supplies to the Royal Thai Army, which helps people in distressed areas across the country. BMI Economic View: Recent trade data reaffirms our view of a subdued economic recovery in Thailand. We believe the present recovery could begin to stagnate over the coming months, especially given the backdrop of cooling global demand. Although we are seeing a strong pickup in automobile exports, the relatively small size of the sector means that robust double-digit growth for automobile exports alone is unlikely to materially affect our subdued outlook for real GDP growth, which we expect to come in at just 4.0% this year. BMI Political View: Having received a green light from the Constitutional Court, we expect the PTP to push ahead with its plans to amend the constitution. The decision has reduced the risks of renewed Red Shirt protests in the short term. However, the political outlook for Thailand remains largely unchanged and we expect the country to remain at risk of falling back into another period of political turmoil.
- Executive Summary
- SWOT Analysis
- Thailand Pharmaceutical And Healthcare Industry SWOT
- Thailand Political SWOT
- Thailand Economic SWOT
- Thailand Business Environment SWOT
- Pharmaceutical Risk/Reward Ratings
- Table: Asia Pacific Pharmaceutical & Healthcare Risk/Reward Ratings, Q412
- Rewards
- Thailand - Market Summary
- Regulatory Regime
- Intellectual Property Regime
- IP Shortcomings
- Counterfeit Drugs
- Compulsory Licensing Regulatory Developments
- IP Developments
- Pricing And Reimbursement
- Table: Price Build-Up of Medicines in Thailand
- Industry Trends And Developments
- Epidemiology
- Healthcare System
- Healthcare Insurance
- Table: Various Healthcare Scheme in Thailand
- Medical Tourism
- Research And Development
- Biosimilars
- Clinical Trials
- Medical Devices
- Developments In The Medical Devices Sector
- Industry Forecast Scenario
- Overall Market Forecast
- Table: Pharmaceutical Sales Indicators 2008-2016
- Healthcare Market Forecast
- Table: Healthcare Expenditure Indicators 2008-2016
- Table: Healthcare Governmental Indicators 2008-2016
- Table: Healthcare Private Indicators 2008-2016
- Key Growth Factors - Macroeconomic
- Prescription Drug Market Forecast
- Table: Prescription Drug Sales Indicators 2008-2016
- Patented Drug Market Forecast
- Table: Patented Drug Market Indicators 2008-2016
- Thailand Pharmaceuticals and Healthcare Report Q4
- © Business Monitor International Ltd Page
- Generic Drug Market Forecast
- Table: Generic Drug Sales Indicators 2008-2016
- OTC Medicine Market Forecast
- Table: OTC Medicine Sales Indicators 2008-2016
- Pharmaceutical Trade Forecast
- Table: Exports and Imports Indicators 2008-2016
- Medical Device Market Forecast
- Table: Medical Devices Sales Indicators 2008-2016
- Other Healthcare Data
- Key Risks To BMI's Forecasts
- Competitive Landscape
- Pharmaceutical Industry Developments
- Pharmaceutical Distribution and Retail
- Company Profiles
- Domestic Companies
- Siam Pharmaceutical
- Government Pharmaceutical Organisation (GPO)
- Government Pharmaceutical Organisation (GPO)
- Biolab
- Thai Meiji Pharmaceutical Company
- Berlin Pharmaceutical Industry
- Multinational Companies
- Pfizer
- Sanofi
- GlaxoSmithKline (GSK)
- Merck & Co
- Novartis
- Demographic Data
- THAILAND - Population By Age Group
- THAILAND - Population By Age Group
- THAILAND - Key Population Ratios
- THAILAND - Rural and Urban Population
- Glossary
- BMI Methodology
- How We Generate Our Pharmaceutical Industry Forecasts
- Pharmaceuticals Business Environment Ratings
- Risk/Reward Ratings Methodology
- Ratings Overview
- Table: Pharmaceutical Business Environment Indicators
- Weighting
- Table: Weighting Of Components
- Sources
